F2G is focused on developing first-in-class medicines to treat rare, life-threatening fungal infections using a proprietary genomic technology platform.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
F2G is focused on developing first-in-class medicines to treat rare, life-threatening fungal infections using a proprietary genomic technology platform.
TenNor Therapeutics is a near-commercial stage biotechnology company dedicated to the discovery, development, and commercialization of differentiated therapies to address unmet me…
BioVersys is a Swiss pharmaceutical company focused on combating antimicrobial resistance through the development of innovative antibacterial therapies. Their pipeline includes no…
BiomX is developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic f…
Venatorx Pharmaceuticals, Inc. is a private pharmaceutical company focused on improving health outcomes for patients with multi-drug-resistant bacterial infections and hard-to-tre…
Vedanta Biosciences is a clinical-stage company developing oral therapies based on defined bacterial consortia to treat gastrointestinal diseases, including recurrent Clostridioid…
Pattern Bioscience is focused on revolutionizing bacterial diagnosis and addressing antibiotic resistance through advanced single-cell microbiology, providing rapid and precise an…
Antabio is a clinical-stage biopharmaceutical company developing novel antibacterial treatments targeting drug-resistant infections identified by WHO and CDC as critical prioritie…
Utility Therapeutics is a developer of antibiotics aimed at treating urinary tract infections and multi-drug resistant infections, known for its product Pivmecillinam.
Peptilogics is a surgical therapeutics company advancing a novel anti-biofilm drug designed to cure and prevent all medical device-related infections.
Centauri Therapeutics is an immunotherapy company currently focused on infectious diseases and oncology. Centauri’s approach to treating infectious diseases rests upon proprietary…
Trellis Bioscience is focused on developing innovative therapies targeting bacteria, viruses, and cancer through advanced scientific research and technology.
Telum Therapeutics is a biotechnology company specializing in drug discovery, leveraging synthetic biology and AI-driven machine learning to develop next-generation antimicrobial…
Elion Therapeutics is a biotechnology company focused on combating life-threatening invasive fungal infections. The company aims to provide new therapies that address critical unm…